E210 - The PsychopharmaStahlogy Show: Potenti...

In this episode of PsychopharmaPearls, Dr. Andy Cutler talks with Dr. Leslie Citrome about akathisia, a common but often misdiagnosed antipsychotic side effect that can look like agitation, anxiety, irritability, or worsening psychiatric symptoms. They discuss how to recognize ak ...  عرض المزيد

This episode features extended Q&A sessions addressing unanswered audience questions from select presentations delivered at the 2026 NEI Spring Congress in Kissimmee, Florida: (00:53) From Avoidance to Action: Evidence-based Pathways to Recovery for Difficult-to-Treat Anxiety by ...  عرض المزيد

Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ...  عرض المزيد

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  عرض المزيد

In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-wor ...  عرض المزيد

Send us Fan MailIn this episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison explore how psychedelic experiences might solicit false or maladaptive beliefs. Learn more about our podcast at https://numinusnetwork.com/learn/podcast/Learn more a ...  عرض المزيد